[Xenopus] Antibody Grant

Lemire, Joan M Joan.Lemire at tufts.edu
Sun Sep 24 16:34:01 EDT 2017


We do not have the xenopus sequences for expression in PCS2.  We have been expressing the mouse sequences.  We could send the longest xenopus clones of each that we have.
I think I said this before, but HCN4 and HCN3 were mis-identified in Xenopus as well as others species.  We have the correct Hcn4 as in in situ probe.

Joan


On Sep 18, 2017, at 6:21 AM, John Gurdon <j.gurdon at gurdon.cam.ac.uk<mailto:j.gurdon at gurdon.cam.ac.uk>> wrote:

Dear Genevieve et al.

Dr Gurdon would be most interested to see this list of antibodies you have against transcription factors if you have this information.

Yours sincerely,
Dilly Bradford
Secretary/PA


On 8 Sep 2017, at 15:59, Almouzni Pettinotti Genevieve wrote:

Super !!!
Bravo
G

Envoyé de mon iPhone

Le 8 sept. 2017 à 16:52, Dominique Alfandari <alfandar at vasci.umass.edu<mailto:alfandar at vasci.umass.edu>> a écrit :

Dear colleagues,
I am happy to say that we have finally received the notice of award for our NIH grant to produce and characterize 100 monoclonal antibody against Xenopus proteins.
This is a 4 year grant that is designed to produce antibodies to membrane protein, signaling receptors and transcription factors using multiple approaches. The essential goal of our project is to produce antibodies that work in embryos by blot/IF/IP.

One part of the project is to identify key proteins, for which there is no cross reacting antibodies, and that are critical for the community. These targets will be produced as flag-tagged protein expressed in Hek293T cells and used to immunize mice.

For people working on transcription factors, I would strongly recommend that you look at the antibodies developed by the DSHB. They provide sup for very cheap. We have been able to test several of them that do cross react (e.g Arid3a, Sox10).

If you are interested and would like (1 to propose a target or (2 be on a committee that help select the highest priority targets, please email me. (Some of you have done this a long time ago but a refresher could be good).

1 what is your target?
2 What did you do to find if existing antibody may cross react?
3 Do you have your full length tagged in CS2 with Flag (any other vector with a CMV promoter is acceptable).

All antibody will be validated on embryo extract/whole mount immunostaining/IP-LC/ms/ms and will be available at the DSHB. The characterization files will be integrated in Xenbase with the appropriate gene page.

I plan to hire 2 technicians for this project (Add to follow).

Thank you for your attention. I hope to hear from you.
Dom

Dominique Alfandari
PhD. Professor
alfandar at vasci.umass.edu<mailto:alfandar at vasci.umass.edu>

_______________________________________________
Xenopus mailing list
Xenopus at lists.mbl.edu<mailto:Xenopus at lists.mbl.edu>
https://lists.mbl.edu/mailman/listinfo/xenopus
_______________________________________________
Xenopus mailing list
Xenopus at lists.mbl.edu<mailto:Xenopus at lists.mbl.edu>
https://lists.mbl.edu/mailman/listinfo/xenopus



Dr John Gurdon
The Gurdon Institute, University of Cambridge,
Tennis Court Road, Cambridge CB2 1QN, United Kingdom

Tel: +44 (0)1223 334090   Fax: +44 (0)1223 334089
Email: j.gurdon at gurdon.cam.ac.uk<mailto:j.gurdon at gurdon.cam.ac.uk>

http://www.gurdon.cam.ac.uk<http://www.gurdon.cam.ac.uk/>




_______________________________________________
Xenopus mailing list
Xenopus at lists.mbl.edu<mailto:Xenopus at lists.mbl.edu>
https://lists.mbl.edu/mailman/listinfo/xenopus

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.mbl.edu/pipermail/xenopus/attachments/20170924/7ed78e6b/attachment.html 


More information about the Xenopus mailing list